Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07123961 · ClinicalTrials.gov registry record · Phase 2
Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial
A Phase 2 study of Acute Respiratory Distress Syndrome (ARDS) and Pediatric Acute Respiratory Distress Syndrome (PARDS), sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT07123961: Recruiting Phase 2 study of Acute Respiratory Distress Syndrome (ARDS) and Pediatric Acute Respiratory Distress Syndrome (PARDS), sponsored by Children's Hospital of Philadelphia.
NCT07123961 is a Phase 2 study of Acute Respiratory Distress Syndrome (ARDS) and Pediatric Acute Respiratory Distress Syndrome (PARDS) that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 160 participants, below the 17,715-participant average among 8 other Acute Respiratory Distress Syndrome (ARDS) trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07123961, a Phase 2 study of Acute Respiratory Distress Syndrome (ARDS) and Pediatric Acute Respiratory Distress Syndrome (PARDS), is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute respiratory distress syndrome (ARDS) is a serious and potentially life-threatening lung condition that can affect children. Currently, ventilator settings commonly used in treatment are based on approaches developed for adults, and it remains unclear whether these settings are equally effective for children. Because children's bodies respond differently than adults', it is important to determine the most effective ventilator strategies specifically for pediatric patients. This study will compare two different ventilator approaches in children with ARDS to identify which method provides the greatest benefit. The findings will also help inform the design of a larger study in the future.
Conditions Studied
Interventions
- OTHER High Driving Pressure Mechanical Ventilation
- OTHER Low Driving Pressure Mechanical Ventilation
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-11-07 |
| Est. Completion | 2030-06-30 |
| Phase | Phase 2 |
What NCT07123961 shows while recruiting
NCT07123961 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 17,715-participant average among 8 other Acute Respiratory Distress Syndrome (ARDS) trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Acute Respiratory Distress Syndrome (ARDS) appearing as the primary indexed condition, and to 2 interventions - of which High Driving Pressure Mechanical Ventilation is the first listed.
NCT07123961 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07123961 about?
NCT07123961 is a clinical study titled "Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial". Acute respiratory distress syndrome (ARDS) is a serious and potentially life-threatening lung condition that can affect children. Currently, ventilator settings commonly used in treatment are based on approaches developed for adults, and it remains unclear whether these settings are equally effectiv...
What is the current status of trial NCT07123961?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2025-11-07. Estimated completion is 2030-06-30.
What conditions does trial NCT07123961 study?
This clinical trial studies the following conditions: Acute Respiratory Distress Syndrome (ARDS), Pediatric Acute Respiratory Distress Syndrome (PARDS), Ventilator Management, Lung-protective Ventilation.
What interventions are being tested in trial NCT07123961?
The interventions under investigation include: High Driving Pressure Mechanical Ventilation (OTHER), Low Driving Pressure Mechanical Ventilation (OTHER).
Who is sponsoring clinical trial NCT07123961?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07123961 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Respiratory Distress Syndrome (ARDS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07123961's enrollment target sits among peer trials
160 7th of 8 higher than 2 of 8 other Acute Respiratory Distress Syndrome (ARDS) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Respiratory Distress Syndrome (ARDS) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RECRUITING · Phase 2
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RECRUITING · Phase 2
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RECRUITING · Phase 2
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
RECRUITING · Phase 2
-
Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS
ACTIVE NOT RECRUITING · Phase 2
-
An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI